NICOX

Dead / Abandoned — Abandoned — no statement of use filed (as of 26 Sept 2022)

What this means for you

This application is over — abandoned 26 Sept 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
90351827
Mark type
Stylized text
Filed
01 Dec 2020
Published for opposition
29 Jun 2021
Abandoned
26 Sept 2022
Attorney of record
John Zaccaria

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of ocular and ophthalmological diseases, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous system disease, musculoskeletal system disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, burns; Dietetic foods adapted for medical use, namely, meal replacement bars, meal replacement and drink mixes; minerals being mineral nutritional supplements and vitamins
  • Class 010 — Medical apparatus: Medical apparatus and instruments for use in the treatment of ocular and ophthalmological disease, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous systems disease, musculoskeletal systems disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, burns; Diagnostic apparatus for medical purposes for detecting ocular and ophthalmological diseases, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous system disease, musculoskeletal system disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, burns
  • Class 035 — Advertising and business services: Online retail and wholesale store services featuring pharmaceutical products, dietary supplements, dietetic substances adapted for medical use, medical apparatus and instruments, and diagnostic apparatus for medical purposes
  • Class 044 — Medical, beauty and agricultural services: Medical evaluation services in the fields of ocular and ophthalmological diseases, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous system disease, musculoskeletal system disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, and burns, for purposes of guiding treatment

Owner

Prior registrations

Prosecution history

  • 26 Sept 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 26 Sept 2022 — ABANDONMENT - NO USE STATEMENT FILED
  • 04 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 31 Dec 2021 — SOU EXTENSION 1 GRANTED
  • 31 Dec 2021 — SOU EXTENSION 1 FILED
  • 31 Dec 2021 — SOU TEAS EXTENSION RECEIVED
  • 24 Aug 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 29 Jun 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 29 Jun 2021 — PUBLISHED FOR OPPOSITION
  • 09 Jun 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 27 May 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 27 May 2021 — EXAMINER'S AMENDMENT ENTERED
  • 27 May 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 27 May 2021 — EXAMINERS AMENDMENT E-MAILED
  • 27 May 2021 — EXAMINERS AMENDMENT -WRITTEN

View this trademark record on Marksy